Advances in Platelet-Rich Plasma Treatment for Spinal Diseases: A Systematic Review
International Journal of Molecular Sciences · 21.04.2023 · 24 (8) · 7677
DOI: 10.3390/ijms24087677 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.04.2023. Verfasst von Soya Kawabata und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, School of Medicine, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Low Back Pain, Platelet-Rich Plasma. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Spinal diseases are commonly associated with pain and neurological symptoms, which negatively impact patients’ quality of life. Platelet-rich plasma (PRP) is an autologous source of multiple growth factors and cytokines, with the potential to promote tissue regeneration. Recently, PRP has been widely used for the treatment of musculoskeletal diseases, including spinal diseases, in clinics. Given the increasing popularity of PRP therapy, this article examines the current literature for basic research and emerging clinical applications of this therapy for treating spinal diseases. First, we review in vitro and in vivo studies, evaluating the potential of PRP in repairing intervertebral disc degeneration, promoting bone union in spinal fusion surgeries, and aiding in neurological recovery from spinal cord injury. Second, we address the clinical applications of PRP in treating degenerative spinal disease, including its analgesic effect on low back pain and radicular pain, as well as accelerating bone union during spinal fusion surgery. Basic research demonstrates the promising regenerative potential of PRP, and clinical studies have reported on the safety and efficacy of PRP therapy for treating several spinal diseases. Nevertheless, further high-quality randomized controlled trials would be required to establish clinical evidence of PRP therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, School of Medicine, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan.
- Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.
ORCID-Profile: Koji Akeda, Junichi Yamada, Akihiro Sudo
Zitieren
APA
Kawabata, S., Akeda, K., Yamada, J., Takegami, N., Fujiwara, T., Fujita, N., & Sudo, A. (2023). Advances in Platelet-Rich Plasma Treatment for Spinal Diseases: A Systematic Review. International Journal of Molecular Sciences, 24(8), 7677. https://doi.org/10.3390/ijms24087677
Vancouver
Kawabata S, Akeda K, Yamada J, Takegami N, Fujiwara T, Fujita N, et al. Advances in Platelet-Rich Plasma Treatment for Spinal Diseases: A Systematic Review. International Journal of Molecular Sciences. 2023;24(8):7677. doi:10.3390/ijms24087677
BibTeX
@article{Kawabata2023,
author = {Kawabata, Soya and Akeda, Koji and Yamada, Junichi and Takegami, Norihiko and Fujiwara, Tatsuhiko and Fujita, Nobuyuki and Sudo, Akihiro},
title = {Advances in Platelet-Rich Plasma Treatment for Spinal Diseases: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7677},
doi = {10.3390/ijms24087677}
}
EUVIMED